APA ציטוט

Stern, N., Wong, K., Dieleman, L. A., Halloran, B. P., Huang, V., Kroeker, K. I., . . . Fedorak, R. (2018). A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN. J Can Assoc Gastroenterol.

Citação norma Chicago

Stern, N., K. Wong, L A. Dieleman, B P. Halloran, V. Huang, K I. Kroeker, F. Peerani, S. van Zanten, and R. Fedorak. "A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN." J Can Assoc Gastroenterol 2018.

ציטוט MLA

Stern, N., et al. "A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN." J Can Assoc Gastroenterol 2018.